top of page
SPRAVATO®: A New Direction in Depression Care
SPRAVATO® (esketamine) is the first FDA-approved nasal spray for treatment-resistant depression in adults. Unlike traditional antidepressants that can take weeks to work, SPRAVATO® can provide relief much faster for many patients.
Who is it for?
Adults who have tried at least two different antidepressant medications without adequate relief from their symptoms.
Medical Supervision
A healthcare provider will be present during your entire treatment session to monitor your response.
As a REMS-certified clinic, we follow strict safety protocols to ensure your treatment is
comfortable and secure.
Your Safety is Our Priority
2-Hour Monitoring
You will remain in our relaxing clinic for at least two hours after administration for observation.
Comfortable Environment
Our treatment rooms are designed to be peaceful and low-stimulus for your comfort.
bottom of page